Results 11 to 20 of about 1,594,274 (317)
Canadian Journal of Gastroenterology and Hepatology, 2022 Objectives. We assessed the potential of glial cell line-derived neurotrophic factor (GDNF) as a useful biomarker to predict cirrhosis in chronic hepatitis B (CHB) patients. Methods.
Guangyue Yang +17 more
doaj +1 more source
Analytical Cellular Pathology, 2022 Nowadays, microRNA-375 (miR-375) has been implicated in many types of cancers, including hepatocellular carcinoma (HCC), and the functions of miRNAs encapsulated by extracellular vesicles (EV) in HCC progression have also been extensively investigated ...
Zhaoxia Yu +5 more
doaj +1 more source
BMC Gastroenterology, 2023 Background Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, and is characterized by insidious onset, rapid progression, and poor prognosis. Immunotherapy is a first-line treatment for advanced HCC.
Rui Hu +13 more
doaj +1 more source
Emergency Medicine International, 2022 Objectives. To investigate the effects of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) on liver function and immune function in patients with hepatocellular carcinoma (HCC). Methods.
Yan Zhou +6 more
doaj +1 more source
Scientific Reports, 2023 Peripheral blood mononuclear cell (PBMC) genes reflect the host immune status and could be suitable for evaluating the prognosis of patients with hepatocellular carcinoma (HCC), for which a reliable biomarker is unavailable and the host immune responses ...
Jing Li +10 more
doaj +1 more source
Postgraduate Medical Journal, 2000 Abstract Alcohol is a major cause of liver cirrhosis in the Western world and accounts for the majority of cases of liver cirrhosis seen in district general hospitals in the UK. The three most widely recognised forms of alcoholic liver disease are alcoholic fatty liver (steatosis), acute alcoholic hepatitis, and alcoholic cirrhosis.
K, Walsh, G, Alexander
openaire +5 more sources
Precision Medical Sciences, 2022 Abnormal SORT1 expression has been reported in various cancers. However, the expression and function of SORT1 in hepatocellular carcinoma (HCC) remain to be explored.
Minjie Lin +5 more
doaj +1 more source
European Journal of Medical Research, 2022 Background Patients with HBV-related acute-on-chronic liver failure (HBV–ACLF) have a high 90-day mortality rate, so early prognostic evaluation is important.
Jian Zhang +3 more
doaj +1 more source
RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma
Scientific Reports, 2021 Hepatocellular carcinoma (HCC) is one of the most common malignant tumors and has extremely high morbidity and mortality. Although many existing studies have focused on the identification of biomarkers, little information has been uncovered regarding the
Zhiyi Han +10 more
doaj +1 more source
International Journal of Hyperthermia, 2019 Objective: This study aimed to evaluate the risk factors of biloma formation and secondary infection after thermal ablation for malignant hepatic tumors.
Jia Liu +8 more
doaj +1 more source